EDGAR Filing Documents for 0001493152-15-000766

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-15-000766

Filing Date

2015-03-09

Accepted

2015-03-09 08:32:20

Documents

Period of Report

2014-09-30

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	621375
2		ex31-1.htm	EX-31.1	16459
3		ex31-2.htm	EX-31.2	10846
4		ex32-1.htm	EX-32.1	4633
5		ex32-2.htm	EX-32.2	4572
	Complete submission text file	0001493152-15-000766.txt		6757697

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE FILE	corx-20140930.xml	EX-101.INS	705593
7	XBRL SCHEMA FILE	corx-20140930.xsd	EX-101.SCH	76990
8	XBRL CALCULATION FILE	corx-20140930_cal.xml	EX-101.CAL	43402
9	XBRL DEFINITION FILE	corx-20140930_def.xml	EX-101.DEF	271971
10	XBRL LABEL FILE	corx-20140930_lab.xml	EX-101.LAB	517580
11	XBRL PRESENTATION FILE	corx-20140930_pre.xml	EX-101.PRE	333715

Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452

Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)